GUNAR K ZAGARS to Multivariate Analysis
This is a "connection" page, showing publications GUNAR K ZAGARS has written about Multivariate Analysis.
Connection Strength
0.225
-
Management of locally recurrent soft-tissue sarcoma after prior surgery and radiation therapy. Int J Radiat Oncol Biol Phys. 2007 Mar 15; 67(4):1124-9.
Score: 0.041
-
Addition of radiation therapy to androgen ablation improves outcome for subclinically node-positive prostate cancer. Urology. 2001 Aug; 58(2):233-9.
Score: 0.028
-
Radiation therapy for T1 and T2 prostate cancer: prostate-specific antigen and disease outcome. Urology. 1995 Mar; 45(3):476-83.
Score: 0.018
-
The prognostic importance of Gleason grade in prostatic adenocarcinoma: a long-term follow-up study of 648 patients treated with radiation therapy. Int J Radiat Oncol Biol Phys. 1995 Jan 15; 31(2):237-45.
Score: 0.018
-
Prostate specific antigen as an outcome variable for T1 and T2 prostate cancer treated by radiation therapy. J Urol. 1994 Nov; 152(5 Pt 2):1786-91.
Score: 0.018
-
The T classification of clinically localized prostate cancer. An appraisal based on disease outcome after radiation therapy. Cancer. 1994 Apr 01; 73(7):1904-12.
Score: 0.017
-
Prognostic factors in prostate cancer. Analysis of 874 patients treated with radiation therapy. Cancer. 1993 Sep 01; 72(5):1709-25.
Score: 0.016
-
Outcomes after definitive treatment for cutaneous angiosarcoma of the face and scalp. Head Neck. 2011 May; 33(5):661-7.
Score: 0.013
-
Retroperitoneal soft tissue sarcoma: an analysis of radiation and surgical treatment. Int J Radiat Oncol Biol Phys. 2007 Jan 01; 67(1):158-63.
Score: 0.010
-
Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial. Int J Radiat Oncol Biol Phys. 2002 Aug 01; 53(5):1097-105.
Score: 0.008
-
Ki-67 staining is an independent correlate of biochemical failure in prostate cancer treated with radiotherapy. Clin Cancer Res. 2002 May; 8(5):1148-54.
Score: 0.007
-
Preliminary results of a randomized radiotherapy dose-escalation study comparing 70 Gy with 78 Gy for prostate cancer. J Clin Oncol. 2000 Dec 01; 18(23):3904-11.
Score: 0.007
-
Prostate specific antigen density as a prognostic factor for patients with prostate carcinoma treated with radiotherapy. Cancer. 1996 Apr 15; 77(8):1515-23.
Score: 0.005
-
Prognostic value of p53 in muscle-invasive bladder cancer treated with preoperative radiotherapy. Urology. 1996 Mar; 47(3):305-10.
Score: 0.005
-
Serum prostate-specific antigen after radiation therapy for clinically localized prostate cancer: prognostic implications. Int J Radiat Oncol Biol Phys. 1994 Sep 30; 30(2):279-87.
Score: 0.004
-
Influence of initial presentation on treatment outcome of clinically localized prostate cancer treated by definitive radiation therapy. Int J Radiat Oncol Biol Phys. 1994 Sep 30; 30(2):331-7.
Score: 0.004
-
Serum prostate-specific antigen, clinical stage, pathologic grade, and the incidence of nodal metastases in prostate cancer. Urology. 1994 Aug; 44(2):215-20.
Score: 0.004